Redundancies to be made at Novo Nordisk's Athlone facility – The Journal
Redundancies to be made at Novo Nordisk’s Athlone facility The JournalNovo Nordisk planning job cuts at its Irish operation RTE.ieNovo…
Novo Nordisk to cut staff numbers at Irish business – The Irish Times
Drugmaker Novo Nordisk is set to cut jobs at its Irish unit. The Danish firm notified the Department…
1 Reason Novo Nordisk (NVO) Is 1 of the Best Healthcare Stocks You Can Buy Today
Novo Nordisk is leading the race to get an oral weight loss GLP-1 drug approved. It needs to…
Trump announces new tariffs on pharmaceuticals from October – The Irish Times
The Government has said a deal capping future US tariffs on imports of pharmaceuticals from Europe still stands,…
GLP-1 Weight-Loss Pills Could Transform Treatment
A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy…
Drug firm publishes clinical trials tripling Ozempic dose for greater weight loss – The Journal
Drug firm publishes clinical trials tripling Ozempic dose for greater weight loss The JournalTriple-strength ‘mega-dose’ of slimming jab outstrips…
How the ‘Ozempic effect’ is reshaping the global economy
Michael Siluk/Alamy The new wave of weight-loss drugs has taken the world by storm. From Novo Nordisk’s Ozempic…
2 Undervalued Healthcare Stocks to Buy in 2025 and Hold for Decades
The overall stock market keeps reaching new heights, but some of its components are having a lousy year.…
Wegovy And Zepbound Cost Effective But They Could Break Drug Budgets
The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative…
Weight-loss drugs becoming better value for money, says watchdog
Popular GLP-1 weight-loss injections are now delivering greater value, according to a new report by a leading pharmaceutical…
How a change in FDA guidance might revolutionise MASH drug development
Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) therapy space,…
Pricing group says weight-loss drugs becoming more cost-effective
By Deena Beasley (Reuters) -An influential drug pricing watchdog on Tuesday said popular GLP-1 weight-loss injections have become…